+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study



Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study



Alimentary Pharmacology and Therapeutics 28(5): 629-637



Between 3% and 40% of patients surviving an episode of upper gastrointestinal bleeding (UGIB) experience a recurrence within 1 year. Aim To characterize further the recurrence rate of UGIB and to investigate the role of long-term acid suppressive therapy in its secondary prevention. Recurrent cases of UGIB were identified among patients registered in The Health Improvement Network in the UK. A nested case-control analysis provided relative risk (RR) estimates of factors associated with recurrence. Of 1287 patients included, 67 (5.2%) were identified with a recurrent UGIB episode, corresponding to a recurrence rate of 17.5 per 1000 person-years during a mean follow-up of 3 years. The greatest risk of recurrence was in patients prescribed the oral anticoagulant warfarin (RR: 5.38; 95% confidence interval: 2.02-14.36). Use of a single proton pump inhibitor (PPIs) was associated with a reduced risk of recurrence (RR: 0.51; 95% confidence interval: 0.26-0.99), even in patients taking warfarin, while current use of H(2)-receptor antagonists was not. After the first episode of UGIB, use of nonsteroidal anti-inflammatory drugs and aspirin was greatly reduced, preventing estimation of the risk associated with these drugs. Long-term PPI therapy reduces the risk of UGIB recurrence.

(PDF emailed within 0-6 h: $19.90)

Accession: 033016759

Download citation: RISBibTeXText

PMID: 18616644

DOI: 10.1111/j.1365-2036.2008.03780.x


Related references

Proton pump inhibitors and long-term risk of recurrent upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics 29(2): 232-233, 2011

Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users. American Journal of Gastroenterology 103(10): 2658-2659, 2008

Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding. Gastroenterology 151(6): 1105-1112.E10, 2016

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding. Bmc Pharmacology and Toxicology 15: 22, 2014

T1149 Risk of Upper Gastrointestinal Bleeding in Clopidogrel and Aspirin Users Receiving Concomitant Proton Pump Inhibitors. Gastroenterology 138(5): S-499, 2010

Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin. Gastroenterology 152(1): 105-110.E1, 2016

Mo1190 - Proton Pump Inhibitors Decrease Upper Gastrointestinal Bleeding in High-Risk Patients on Dual Antiplatelet Therapy. Gastroenterology 154(6): S-701, 2018

Tumour necrosis factor-alpha polymorphism increases risk of nonvariceal upper gastrointestinal bleeding among patients taking proton pump inhibitors. Canadian Journal of Gastroenterology and Hepatology 28(9): 488, 2015

Proton-pump inhibitors for upper-gastrointestinal bleeding. American Journal of Health-System Pharmacy 63(3): 214, 216, 2006

Proton pump inhibitors and upper gastrointestinal bleeding. Gastroenterologie Clinique et Biologique 29(2): 137-139, 2005

Proton-pump inhibitors for upper-gastrointestinal bleeding. American Journal of Health-System Pharmacy 63(3): 216-217, 2006

Risk of Both upper and Lower Gastrointestinal Bleeding Associated with Low-Dose Acetylsalicylic Acid and Proton Pump Inhibitors Among Nearly 400,000 Individuals in Routine General Practice in the United Kingdom. Gastroenterology 154(6): S-136-S-137, 2018

Proton-Pump Inhibitor (Ppi) Versus Histamine-2 Receptor Antagonist (H2Ra) for the Prevention of Recurrent Non-Variceal Upper Gastrointestinal Bleeding in High-Risk Users of Low-Dose Aspirin (Asa). Gastroenterology 150(4): S188-S189, 2016

Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics 24(8): 1247-1255, 2006

Proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding. Journal of Gastroenterology and Hepatology 21(11): 1763-1765, 2006